SCHEMBL51834

SCHEMBL51834

CCOC(=O)c1cc(OCC)cc2c1Cc1ccccc1[S+]2[O-]

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.40
▸ LMNA P02545 4/20 0.39
▸ GAA P10253 3/20 0.39
▸ KDM4E B2RXH2 3/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ ALDH1A1 P00352 7/20 0.38
▸ MAPT P10636 5/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ HSP90AA1 P07900 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ GABRP O00591 1/20 0.38
▸ GABRD O14764 1/20 0.38
▸ GABRA1 P14867 1/20 0.38
▸ GABRB1 P18505 1/20 0.38
▸ GABRG2 P18507 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9455916 0.91 TSHR (0.40) TSHRLMNAGAAKDM4ETDP1
SCHEMBL51134 0.85 TSHR (0.41) TSHRLMNAKDM4ETDP1HTT
SCHEMBL51941 0.85 ALDH1A1 (0.43) TSHRLMNAGAAKDM4ETDP1
SCHEMBL9456118 0.83 TSHR (0.50) TSHRLMNAKDM4EALDH1A1MAPT
SCHEMBL10831575 0.83 SMN1; SMN2 (0.42) TSHRLMNANPC1ALDH1A1MAPT
SCHEMBL11169689 0.83 TSHR (0.39) TSHRLMNAGAAKDM4ETDP1
SCHEMBL10806484 0.82 TSHR (0.38) TSHRGAAKDM4ETDP1NPC1
SCHEMBL11173009 0.81 HSP90AA1 (0.38) TSHRKDM4ETDP1ALDH1A1MAPT
SCHEMBL10830507 0.80 TSHR (0.36) TSHRLMNAGAAKDM4ETDP1
SCHEMBL11167136 0.79 KDM4E (0.39) TSHRLMNAGAAKDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 588 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11382868-B2 Transdermal UV-curable hydrogel resin, hydrogel curing the same and cataplasm containing the same ICURE PHARMACEUTICAL INC. (KR) 2022-07-12 — — US claimed
CN-107652222-B Oxime ester photoinitiators 巴斯夫欧洲公司 2021-09-10 — — CN claimed
US-10919909-B2 Photoinitiated reactions LINTFIELD LIMITED (GB) 2021-02-16 — — US claimed
US-20190211031-A1 PHOTOINITIATED REACTIONS LINTFIELD LIMITED (GB) 2019-07-11 — — US claimed
US-20190046463-A1 ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME ICURE PHARMACEUTICAL INC. (KR) 2019-02-14 — — US claimed
EP-3415141-A1 ULTRAVIOLET-HARDENING HYDROGEL RESIN AND HYDROGEL FOR TRANSDERMAL ADMINISTRATION, AND CATAPLASM AGENT CONTAINING SAME Icure Pharmaceutical Inc. (KR) 2018-12-19 — — EP claimed
EP-2190887-B1 PHOTOINITIATORS FOR ENERGY CURING LAMBERTI SPA (IT) 2011-05-04 — — EP claimed
US-20100196826-A1 Photoinitiators for Energy Curing LAMBERTI SPA (IT) 2010-08-05 — — US claimed
US-20100093883-A1 Hydroxamic Esters as Photoinitiators LAMBERTI SPA (IT) 2010-04-15 — — US claimed
EP-2121323-A1 HYDROXAMIC ESTERS AS PHOTOINITIATORS Lamberti Spa (IT) 2009-11-25 — — EP claimed
WO-2008104436-A1 HYDROXAMIC ESTERS AS PHOTOINITIATORS LAMBERTI SPA (IT) 2008-09-04 — — WO claimed
US-12637600-B2 Photocurable composition, cured product of same, photofusible resin composition and adhesive set RESONAC CORPORATION (JP) 2026-05-26 — — US disclosed
US-20260132243-A1 THERMOSETTING COMPOSITION AND CURED PRODUCT THEREOF, PHOTOMELTABLE COMPOSITION, AND STRUCTURAL BODY PRODUCTION METHOD RESONAC CORP (JP) 2026-05-14 — — US disclosed
EP-4410859-B1 THERMOSETTING COMPOSITION AND CURED PRODUCT THEREOF, PHOTO-MELTABLE COMPOSITION, AND STRUCTURAL BODY PRODUCTION METHOD RESONAC CORP (JP) 2026-04-29 — — EP disclosed
US-20260051498-A1 Electrode for Lithium Secondary Battery and Method for Manufacturing the Same LG CHEM, LTD. (KR) 2026-02-19 — — US disclosed
US-4992547-A Aminoaryl ketone photoinitiators CIBA-GEIGY CORPORATION (US) 1991-02-12 — — US disclosed
EP-0287516-A2 Photopolymerizable adhesives CIBA-GEIGY AG (CH) 1988-10-19 — — EP disclosed
EP-0138754-B1 PHOTOCURABLE COMPOSITIONS CIBA-GEIGY AG (CH) 1988-05-25 — — EP disclosed
EP-0138754-A2 Photocurable compositions CIBA-GEIGY AG (CH) 1985-04-24 — — EP disclosed
US-4385182-A SENSITIZERS OR PHOTOINITIATORS CIBA-GEIGY CORPORATION (US) 1983-05-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12637600-B2 Photocurable composition, cured product of same, photofusible resin composition and adhesive set ESD, CDH1, ASH2L TSHR 2827/4885LMNA 2269/4885GAA 4629/4885
US-10919909-B2 Photoinitiated reactions KMO, DECR1, PPOX TSHR 3231/4885LMNA 1037/4885GAA 1253/4885
US-20100196826-A1 Photoinitiators for Energy Curing PPOX, ECPAS, PTGES TSHR 4756/4885LMNA 1186/4885GAA 3154/4885
US-20190211031-A1 PHOTOINITIATED REACTIONS DOHH, PAH, DBH TSHR 4176/4885LMNA 786/4885GAA 960/4885
US-20260051498-A1 Electrode for Lithium Secondary Battery and Method for Manufacturing the Same ILK, EPCAM, L1CAM TSHR 4181/4885LMNA 578/4885GAA 4085/4885
US-20260132243-A1 THERMOSETTING COMPOSITION AND CURED PRODUCT THEREOF, PHOTOMELTABLE COMPOSITION, AND STRUCTURAL BODY PRODUCTION METHOD RER1, OXTR, MAP1LC3A TSHR 1945/4885LMNA 2965/4885GAA 3763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback